Related Experiment Videos
First reported case of Aspergillus granulosus infection in a cardiac transplant patient
M G Fakih1, G E Barden, C A Oakes
1Department of Medicine and Microbiology Laboratory, Department of Veterans Affairs Medical Center, Buffalo, NY 14215.
Abstract:
We report a case of disseminated infection with Aspergillus granulosus in a cardiac transplant recipient on immunosuppressive therapy. This is the first reported case in which this organism has been described as a pathogen. This organism bears morphological features different from those of more common Aspergillus species and should be considered a potential pathogen in immunocompromised patients.
Insights
A rare Aspergillus granulosus fungus caused a disseminated infection in a heart transplant patient. This finding highlights a new potential pathogen for immunocompromised individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Transplant Medicine
Background:
- Immunosuppressive therapy following cardiac transplantation significantly increases the risk of opportunistic infections.
- Disseminated fungal infections pose a serious threat to transplant recipients, often requiring prompt diagnosis and treatment.
Observation:
- A case of disseminated infection caused by Aspergillus granulosus was identified in a cardiac transplant recipient.
- The patient was undergoing standard immunosuppressive therapy at the time of infection.
Findings:
- Aspergillus granulosus is reported for the first time as a causative agent of disseminated infection.
- Morphological characteristics of Aspergillus granulosus differ from common Aspergillus species, aiding in its identification.
Implications:
- Aspergillus granulosus should be recognized as a potential opportunistic pathogen in immunocompromised patients, particularly transplant recipients.
- Enhanced diagnostic awareness and consideration of less common Aspergillus species are crucial for managing infections in this vulnerable population.